Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.
NCT06994208 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2025-12-19
Summary
The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group.
Secondary objectives are the following:
* To identify risk factors associated with melanoma in young people.
* To characterise the phenotype and dermoscopic features of melanoma in patients aged 18-39 years.
* To analyse the relationship between the clinical and histopathological features of melanoma in young people.
* To identify the mutational status of B-RAF in the sample of patients analysed.
Conditions
- Melanoma of Skin
Sponsors & Collaborators
-
Ente Ospedaliero Ospedali Galliera
lead OTHER
Principal Investigators
-
Sanja Javor · Ente Ospedaliero Ospedali Galliera
Eligibility
- Min Age
- 18 Years
- Max Age
- 39 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-12-02
- Primary Completion
- 2027-09-01
- Completion
- 2028-08-31
Countries
- Italy
Study Locations
More Related Trials
-
Identification of Metabolic Phenotypes Associated With Melanoma Metastasis
NCT06400550 ·Status: RECRUITING
-
Study of Families With Melanoma
NCT00445783 ·Status: UNKNOWN
-
Genetic Risk Factors and Acquired Oncogenic Mutations of Melanoma
NCT00849407 ·Status: UNKNOWN
-
Cutaneous Squamous Cell Carcinoma Staging Study
NCT05695222 ·Status: RECRUITING
-
Study of Metabolic Changes in the Transformation Malignant Precancerous Skin Lesions
NCT04389112 ·Status: UNKNOWN ·Phase: NA
-
Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults
NCT06680323 ·Status: RECRUITING
-
Head and Neck Melanoma; Access to Staging and Surgical Treatment
NCT05900102 ·Status: COMPLETED
-
Study of Risk Factors and Clinical Characterization of Rapidly Growing Melanoma
NCT02879474 ·Status: UNKNOWN
-
Tracing Dissemination of Melanoma Cells in Healthy Tissues
NCT02854124 ·Status: COMPLETED
-
Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States
NCT03199846 ·Status: COMPLETED
-
GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
NCT01245062 ·Status: COMPLETED ·Phase: PHASE3
-
Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face
NCT01720407 ·Status: COMPLETED ·Phase: PHASE3
-
Descriptive Observational Study on the Characteristics of Advanced and Metastatic Melanoma in Spain
NCT03605771 ·Status: RECRUITING
-
Neoadjuvant L19IL2/L19TNF- Pivotal Study
NCT02938299 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Gene Expression Profiles and ctDNA for Risk Stratification in Patients With Melanoma
NCT06566404 ·Status: NOT_YET_RECRUITING
-
Investigating Participation Patterns Among Stage IV Melanoma Patients
NCT06093594 ·Status: NOT_YET_RECRUITING
-
Itch and Pain Characteristics in Skin Carcinomas
NCT03290989 ·Status: COMPLETED
-
Intratumoral Administration of L19IL2/L19TNF
NCT02076633 ·Status: COMPLETED ·Phase: PHASE2
-
Follow-up of a National Cohort of Melanoma Resectable Stage II, Stage III or IV Patients or Unresectable Primary
NCT02828202 ·Status: RECRUITING
-
One-year Recurrence-free Survival of Melanoma Patients Eligible for a Sentinel Lymph Node Biopsy
NCT06809491 ·Status: ACTIVE_NOT_RECRUITING
-
Study of First-line Treatment Patterns and Clinical Outcomes in Patients With Advanced Melanoma in the United Kingdom
NCT03448497 ·Status: COMPLETED
-
Passive Versus Active Educational Interventions for Melanoma Recognition
NCT04507048 ·Status: COMPLETED ·Phase: NA
-
A Study to Test the Benefit of a New Anti-cancer Treatment in Patients With Unresectable Advanced Melanoma
NCT00942162 ·Status: COMPLETED ·Phase: PHASE2
-
Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions
NCT05907551 ·Status: UNKNOWN
-
RCT Treatment Versus Non Treatment of Low-risk BCCs in Elderly
NCT05110924 ·Status: TERMINATED ·Phase: NA